UPDATE : Monday, July 13, 2020
Meditoxin’s future uncertain, even as final verdict nears by Jeong Sae-im 2020-05-25 14:38
Fall in new Covid-19 cases hampers developing treatment by Jeong Sae-im 2020-05-22 17:31
[Exclusive] Thailand recalls Medytox’s botulinum toxin by Jeong Sae-im 2020-05-21 12:33
Plastic surgeons plead for mercy in nixing Meditoxin's license by Jeong Sae-im 2020-05-20 15:40
‘Speed of Covid-19 vaccine development unprecedentedly fast’ by Jeong Sae-im 2020-05-18 17:04
Medytox’s earnings plummet amid lawsuit against Daewoong by Jeong Sae-im 2020-05-18 11:33
[News Focus] Will Sanofi’s abrupt drop of diabetes study hurt commercial value of Hanmi drug? by Jeong Sae-im 2020-05-15 13:14
Why did Kolon change Invossa contract manufacturer to Lonza? by Jeong Sae-im 2020-05-14 12:03
‘Sarpogrelate beneficial for elderly diabetic patients using antiplatelet agent’ by Jeong Sae-im 2020-05-12 17:32
Shinpoong, Bukwang stocks jump on Covid-19 drug candidates by Jeong Sae-im 2020-05-11 12:03
Daewoong’s BTX sales growth offset by lawsuit expenses by Jeong Sae-im 2020-05-08 12:01
Cellivery sure to win licensing deal with top pharma company by Jeong Sae-im 2020-05-07 11:27
Anticipation for Korean BTX approval in China grows strong by Jeong Sae-im 2020-05-06 11:53
Korean drugmakers’ Q1 earnings rose despite Covid-19 by Jeong Sae-im 2020-05-01 14:45
Kolon to return $12.3 million upfront payment to Mundipharma by Jeong Sae-im 2020-05-01 11:23
Court rejects Medytox’ request to stop administrative order on BTX suspension by Jeong Sae-im 2020-04-29 17:11
‘Pexa-Vec with immunotherapy reduced tumor in 75% of kidney cancer patients’ by Jeong Sae-im 2020-04-28 17:35
Genexine’s cervical cancer DNA vaccine boosts Keytruda’s response rate by Jeong Sae-im 2020-04-28 14:48
Kolon begins testing gene therapy for neuropathic pain in US by Jeong Sae-im 2020-04-27 16:18
Reform panel tells regulator to retain consigned bioequivalence tests by Jeong Sae-im 2020-04-27 13:38
Back to Top